BISSANTZ CATERINA has a total of 32 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are MSD CO LTD, HEXAL PHARMACEUTICALS INC and WILLIAMS PETER D.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 28 | |
#2 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bissantz Caterina | 32 |
#2 | Ratni Hasane | 26 |
#3 | Rogers-Evans Mark | 23 |
#4 | Schnider Patrick | 23 |
#5 | Grundschober Christophe | 22 |
#6 | Masciadri Raffaello | 19 |
#7 | Ullmer Christoph | 4 |
#8 | Dehmlow Henrietta | 4 |
#9 | Richter Hans | 4 |
#10 | Riemer Claus | 4 |
Publication | Filing date | Title |
---|---|---|
US2012316147A1 | Pyridine derivatives as agonists of the CB2 receptor | |
US2012232051A1 | 3-amino-pyridines as GPBAR1 agonists | |
US2011178089A1 | 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds | |
WO2009049791A2 | Radiolabeled nk3 receptor antagonist | |
US2008161316A1 | Indoles |